We have demonstrated that synaptosomal Lcystine uptake occurs primarily by a sodiumdependent mechanism that involves the X,,(;-high-affinity glutamate transporters. However, it is apparent that the sites to which glutamate and cystine bind on these proteins are not the same, and the full implication of this, in terms of the physiological role of this transport system, and how it would be affected by pathological conditions remains to be determined. 
Introduction
Following neurotransmitter release, rapid highaffinity re-uptake of serotonin [S-hydroxytryptamine (5-HT)] is mediated by the serotonin transporter (SERT). S E R T belongs to a large family of sodium-dependent neurotransmitter transporters [1, 2] . These transporters play a crucial role for normal brain function by regulating the neurotransmitter level in the synaptic cleft. Multiple pathways have been implicated in transporter regulation and recent evidence suggests that one important mechanism for the modulation of transport activity is the regulation of the number of transporter molecules available at the cell surface (reviewed in [3, 4] ). In addition, endogenous substrates and antagonists also seem to have a critical influence on this process [5, 6] . However, our knowledge about the molecular mechanisms and the proteins involved in the regulation of neurotransmitter transporters is still limited.
Previous findings indicate that posttranslational modifications by protein kinases play an important role in the regulation of transporters. Activation of protein kinase C (PKC) leads to an acute down-regulation of . This down-regulation is accompanied by a redistribution of the transporter from the cell surface to internal sites. Increased phosphorylation of S E R T after the activation of P K C has been demonstrated by radioactive labelling in vizio [8] ; however, no phosphorylation site has yet been identified. PKC-dependent down-regulation has emerged as a common scheme for the modulation of neurotransmitter transporter function and was observed in several members of this protein family [9-113. However, the mechanism by which the activation of PKC translates into subcellular redistribution of these transporters remains largely unknown. It is thought that specific regulatory proteins involved in subcellular trafficking may interact with S E R T and other transporters, depending on their phosphorylation state. In this article we summarize recent progress in our laboratory towards the identification and characterization of proteins that interact directly with SERT, regulate the transporter activity and may be involved in subcellular trafficking of the transporter.
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SERT is regulated by syntaxin I A
One potential regulatory protein is the neuronal SNARE (soluble N-ethylmaleimide-sensitive factor-attachment protein receptor) protein syntaxin 1A (SynlA). SynlA is a synaptic plasma membrane protein involved in trafficking and vesicle fusion, as well as in the regulation of ion channels [12] [13] [14] . Neurotransmitter transporters for paminobutyric acid (GABA) and glycine were recently found to be functionally regulated by SynlA [15-171. SynlA interacts with the N-terminal cytoplasmic domain of the GABA transporter (GAT1 ) in a PKC-dependent manner, resulting in a down-regulation of GABA transport [15, 16] . Given that S E R T is closely related to GABA and glycine transporters, it seemed likely that SynlA also regulates the serotonin transporter. Here, we provide evidence that SynlA interacts with S E R T and modulates the cell-surface expression of the transporter.
First, we found that the transfection of SynlA cDNA into HEK-293 cells that stably express rat S E R T (HEKSERT cells) resulted in a reduction of 5-HT uptake ( Figure 1A ). T h e decrease in 5-HT uptake is due to a change in V,,, (9.1 f 0.1 and 3.6 & 0.16 pmol/well per min for mocktransfected and Synl A cDNA-transfected cells, respectively), rather than an alteration in K,, (453 f 13 and 372 f 46 nM 5-HT, respectively).
A similar effect on 5-HT uptake is seen following PKC activation by phorbol esters [7] . Thus, the question arises as to whether the same pathway mediates the effects of SynlA and P K C on S E R T function. For GAT1 it was shown that PKC-mediated down-regulation of GABA transport required the presence of SynlA [15] . SERTmediated 5 -H T uptake is reduced by approx. 50 O,, in HEK-293 cells that were transfected with S E R T cDNA alone following PKC activation (Figure 1 B) , thereby confirming previous findings [7, 8] . However, these cells do not express SynlA as judged from Western blot analysis (unpublished observation). Thus, P K C activation appears to affect S E R T function independently of Synl A. When HEK-293 cells were co-transfected with S E R T and SynlA cDNA, 5-HT uptake in the absence of PMA is reduced by approx. 40"" ( Figure 1B) . However, the effects of SynlA and the phorbol ester PMA do not seem to be additive ( Figure 1B ). This may suggest either that P K C activation and SynlA inhibit S E R T activity through the same, saturable pathway or, that the presence of SynlA renders S E R T partially resistant or inaccessible to PKC-mediated downregulation.
In order to determine whether the SynlA effect is due to a direct interaction with SERT, we performed a glutathione S-transferase ( G S T ) pull-down assay. T h e N-terminal domain of S E R T [NSERT (amino acid residues 1-1 15)], which contains the first potential transmembrane helix ( T M H l ) , was expressed as a G S T fusion protein in Escherichia cofi. This GST-NSERTl 15
Sepharose beads and incubated with lysates of HEK-293 cells, which had been transfected with SynlA cDNA. As shown in Figure 1 (C) SynlA binds to GST-NSERT1 15, but not to GST alone.
SynlA binds also to GST-NSERT90, containing the N-terminal tail of S E R T only, but binding is much weaker than to the longer form, indicating that the T M H l of S E R T contributes to the interaction with Synl A. Using G S T -N S E R T l l 5, we were also able to 'pull-down' SynlA from protein was immobilized on glutathionesolubilized rat brain synaptosomes (data not supplemented with I0 mM glucose. After preincubation for I5 min in TB buffer, uptake was started by adding various concentrations of 5-HT containing ['H]5-HT at approx. I Cilmmol. Cells were incubated for 6 min. and uptake was stopped by removing the 5-HT solution and immediately adding cold TB buffer containing I p M paroxetine. Cells were washed twice more with cold TB and then lysed in 2% SDS. Radioactivity in the lysates was determined by liquid scintillation counting. Non-specific uptake was determined in the presence of I0 p M paroxetine.
Uptake for each 5-HT concentration was determined in triplicate and a representative of three independent experiments is shown. Data were analysed using the Sigmaplot programme package, and V, , and were determined by non-linear regression analysis. (B) Effects of Syn I A and PMA on SERT-mediated 5-HT uptake. Transfection of SERT and Syn I A cDNAs into HEK-293 cells, and 5-HT uptake were performed as described above, except that a single 5-HT concentration ( I pM) was used. Prior to uptake, cells were incubated in TB buffer containing PMA ( I pM) or equal volumes of dimethyl sulphoxide (control) for 30 min at 37 "C. (C) Direct interaction of SynlA with NSERTI 15. GST or the indicated GST fusion proteins were immobilized onto GSH-Sepharose beads and were incubated under standard conditions (0.2% Triton X-I00 in PBS) with cell lysates from HEK-293 cells that were transfected previously with Syn I A cDNA. Beads were washed and bound proteins were eluted with SDS-sample buffer. Syn I A was detected by standard Western blot analysis using a monoclonal mouse antisyntaxin I antibody (Santa Cruz Biotechnology). (D) The interaction of Syn I A with NSERT I I5 is inhibited with increased Triton X-100 concentration. GST pull-down assays were performed as described above, except that NaCl and Triton X-I00 concentrations were changed as indicated. is enhanced in the presence of 0.5 M NaCl ( Figure   1D ). On the other hand, binding appears to be inhibited by increased concentrations of Triton X-100, as Syn 1 A binding is strongly decreased in the presence of 0.5",, and 1 ",, Triton X-100, as compared with 0.2",, Triton X-100 (Figure 1 D) . This might suggest, that binding between S E R T and Syn 1 A is driven by hydrophobic interaction.
T h e change in the transport capacity ( V,,,,,,) of S E R T in the presence of SynlA, as described above, may suggest a reduction of the number of functional transporters at the cell surface. Using a HEK-293 cell line that stably expresses rat S E R T containing a C-terminal FLAG-tag (lmi270 cells),
we studied the subcellular distribution of SERT in the absence and presence of SynlA. In non-or mock-transfected Imi270 cells SERT appears to localize almost exclusively to the plasma membrane ( Figure 2A ). In cells transfected with SynlA cDNA, however, a large portion of S E R T co-localizes with Syn 1 A in intracellular clusters ( Figure 2C ). S E R T appears to be 'trapped' with SynlA inside the cell. Thus, the observed reduction in 5 -H T uptake in the presence of SynlA is most likely to be due to a decrease in the number of transporter molecules expressed at the cell surface. At this stage we are not able to state whether Synl A prevents recycling of previously internal-
ized S E R T or whether newly synthesized S E R T is prevented from trafficking to the plasma
Co-localization of SERT and Syn I A lmi270 cells or the HEK-293 parental cell line were growth for 3 days on poly-L-lysine-treated covenlips and then fixed with acetone (100%) for 10 min at -20 "C. As indicated. cells were transfected with Syn I A cDNA by calcium phosphate precipitation (B and C). Cells were labelled with anti-FLAG M2 monoclonal antibody (Sigma) and fluorescein isothiocyanateconjugated donkey anti-mouse IgG (Jackson IR). andlor with rabbit anti-syntaxin I antibody (Calbiochem) and Texas Red-conjugated donkey anti-rabbit IgG (Jackson IR). Cells were mounted in 50% glycerol/PBS containing 2 mg/ml para-phenylenediamine. Images were acquired with a Kr/Ar laser confocal microscope (MRC-I024 system. BioRad) with a 60 x oil objective lens, using sequential imaging in double-labelled specimens with identical settings t o avoid any cross-talk between the two fluorochromes. Images were processed using Photoimpact 4.2. T h e authors demonstrate that in these cell lines SynlA remains stuck in the Golgi-trans-Golgi network ( T G N ) area and this results in a blockage of membrane and secretory protein transport to the cell surface. However, the regulatory protein rbSecl /Muncl8 was found to rescue Syn 1 A transfer to the plasma membrane.
Interestingly, this study also showed that the GABA transporter, G A T l , is among the proteins that are affected by the Synl A-induced membrane traffic disruption [ 181. As mentioned earlier, SynlA was recently found to bind directly to G A T l and to regulate the GABA uptake activity by decreasing the turnover number of the transporter [ 15,161. Moreover, Muncl8 has been shown to play a critical role in SynlA-dependent G A T l regulation [15] . T h e activity of glycine transporters ( G L Y T l and GLYT2) was also shown to be decreased by Syn 1 A and this effect is abolished in the presenceof Muncl8 [17] . Furthermore, SynlA seems to regulate the cell-surface expression of G L Y T 2 [ 191. Taken together, these findings suggest that SynlA might have a dual role in the regulation of neurotransmitter transporters, i.e. regulating both the cell-surface expression as well as the transport activity. T h e data we have obtained so far for the 5 -H T transporter indicate that SynlA inhibits the trafficking of S E R T to the plasma membrane, thus reducing the number of functional transporters at the cell surface. It remains to be shown whether SynlA also affects the transport activity of S E R T directly.
Identification of novel SERTinteracting proteins using the yeast two-hybrid system
T h e N-and C-terminal domains of S E R T are thought to be located in the cytoplasm and they also contain a number of potential phosphorylation sites. Thus, these domains are the most likely target binding sites for directly interacting, potential regulatory proteins. In order to identify novel serotonin transporter binding proteins (STBP), we performed a yeast two-hybrid screen with the N-terminal domain of S E R T using the interaction trap method [20] . T h e fusion of the DNA-binding protein LexA with N S E R T l l 5 was used as the bait to screen a rat brain cDNA library fused to the B42 transcription activation domain. Six different classes of clones that interact specifically with NSERT115 in the yeast twohybrid analysis were identified. Here we summarize recent progress towards the elucidation of the biological relevance of some of these clones as potential SERT-regulatory proteins.
T h e most frequently obtained cDNA (Class I clones; a representative member is clone 1, designated STBP1) encodes a protein with a high degree of similarity to glycerol kinase-like proteins, GKLP-1 and GKLP-2, found in mouse [21] . T h e mouse proteins d o not display any glycerol kinase activity, and like S T B P l , but in contrast with glycerol kinases, they contain a putative transmembrane domain at the Cterminus. T h e function of these glycerol kinaselike proteins remains unknown.
Using the G S T pull-down assay (as described above) we could verify the direct interaction of S T B P l , expressed HEK-293 cells, with N S E R T l l 5 (unpublished work). In order to study possible functional consequences of the interaction of S T B P l with S E R T in z i v o , we expressed the STBPl cDNA in H E K S E R T cells. Preliminary data suggest that S T B P l does not affect 5 -H T uptake activity. Further studies, including co-immunoprecipitation and confocal microscopy, will be necessary to elucidate the biological relevance of S T B P for S E R T function.
Class I 1 clones (a representative member is STBPl3) are highly similar to the C-terminal part (approx. 200 amino-acid residues) of the hypothetical human brain protein, KIAA0627
[22]. This large ( > 100 kDa) protein has been shown recently to correspond to the novel CLIPassociated protein, CLASP2, from mouse [23] . CLASPS co-localize with CLIPS at microtubule distal ends and are thought to be involved in the regulation of microtubule dynamics. Interestingly, it has been suggested that biogenic amine transporters are associated with cytoskeletal proteins (reviewed in [4]), although no such protein has yet been identified. Thus, STBP13 may represent a promising candidate protein, which could be involved in the anchoring of S E R T to the cytoskeleton and in the subcellular trafficking of the transporter. T h u s far we have been unable to 14-3-3-r interacts with SERT and regulates the transport activity (A) GST pull-down assays were performed as described for Figure I , except that lysates from untransfected HEK-293 cells were used. 14-3-3-r was detected with an isoform-specific rabbit polyclonal antibody (Santa Cruz Biotechnology). (B) Transfection and 5-HT uptake assay were performed as described for Figure I (B) .
express STBP13, i.e. the C-terminal part of CLASP2, in HEK-293 cells. However, we have recently obtained the corresponding full-length cDNA clone, i.e. KIAA0627, from the Kazusa DNA Research Institute in Japan and are currently developing suitable assays to study the role of this protein for S E R T localization and function.
T h e Class 111 clones (a representative member is clone 14 or STBP14) encode the N-terminally truncated 0-or 5-isoforms of the 14-3-3 protein family. 14-3-3 Proteins have been implicated in a number of signalling pathways and have emerged as a class of adapter proteins involved in initiating and stabilizing a variety of protein-protein interactions (reviewed in [24] ).
In order to verify the interaction of this protein with N S E R T l l 5 , we used the G S T pulldown assay as described above. As shown in Figure 3 (A), 14-3-3-5, which is expressed endogenously in HEK-293 cells, binds to GSTNSERTl15, but not to G S T alone, thereby confirming a direct interaction between S E R T and 14-3-3-5.
We also wanted to see whether 14-3-3-r could influence S E R T function in P~P * O .
T h e clone we have isolated in the yeast two-hybrid screen (designated STBPl4S) lacks the N-terminal 38 amino-acid residues of 14-3-3-5, a region involved in the dimerization of the protein [25] . We obtained the full-length clone (designated STBP14L) by PCR from a rat brain cDNA library. Transfection of STBP14L leads to a 3-10-fold over-expression of 14-3-3-5 in HEK-293 and HEKSERT cells, depending on the transfection efficiency. STBP14S is expressed at similar level in these cells. Overexpression of STBP14L, but not of S'I'BPIIS, results in a small reduction of 5-HT uptake in HEKSERT cells ( Figure 3B ). This suggests that 14-3-3-5 inhibits SERTmediated 5-HT uptake. In addition, this in ciao effect depends on the presence of the N-terminal domain of 14-3-3-r, indicating that dimerization of 14-3-3-5 is required for SERT-regulation. Saturation kinetic analysis revealed that the reduction in uptake is due to a decrease in v,,,,;
there is little effect on K,,, (data not shown). At this stage we can only speculate about the possible mechanism by which 14-3-3-r inhibits 5-HT uptake. Our preliminary data suggest a possible involvement in the PKC-dependent regulatory pathway. However, additional experiments will be required to confirm this hypothesis.
Summary
Taken together, our studies suggest that the S E R T is the target for several regulatory proteins. In particular, the trafficking of the transporter to and from the plasma membrane may involve multiple transporter-associated proteins. Further studies will be necessary to elucidate the mechanisms by which these proteins influence the subcellular localization and/or the transport rate of SERT.
